<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37184603</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1420-9071</ISSN><JournalIssue CitedMedium="Internet"><Volume>80</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>15</Day></PubDate></JournalIssue><Title>Cellular and molecular life sciences : CMLS</Title><ISOAbbreviation>Cell Mol Life Sci</ISOAbbreviation></Journal><ArticleTitle>Neurofilament accumulations in amyotrophic lateral sclerosis patients' motor neurons impair axonal initial segment integrity.</ArticleTitle><Pagination><StartPage>150</StartPage><MedlinePgn>150</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">150</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00018-023-04797-6</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is the most common motor neuron (MN) disease in adults with no curative treatment. Neurofilament (NF) level in patient' fluids have recently emerged as the prime biomarker of ALS disease progression, while NF accumulation in MNs of patients is the oldest and one of the best pathological hallmarks. However, the way NF accumulations could lead to MN degeneration remains unknown. To assess NF accumulations and study the impact on MNs, we compared MNs derived from induced pluripotent stem cells (iPSC) of patients carrying mutations in C9orf72, SOD1 and TARDBP genes, the three main ALS genetic causes. We show that in all mutant MNs, light NF (NF-L) chains rapidly accumulate in MN soma, while the phosphorylated heavy/medium NF (pNF-M/H) chains pile up in axonal proximal regions of only C9orf72 and SOD1 MNs. Excitability abnormalities were also only observed in these latter MNs. We demonstrate that the integrity of the MN axonal initial segment (AIS), the region of action potential initiation and responsible for maintaining axonal integrity, is impaired in the presence of pNF-M/H accumulations in C9orf72 and SOD1 MNs. We establish a strong correlation between these pNF-M/H accumulations, an AIS distal shift, increased axonal calibers and modified repartition of sodium channels. The results expand our understanding of how NF accumulation could dysregulate components of the axonal cytoskeleton and disrupt MN homeostasis. With recent cumulative evidence that AIS alterations are implicated in different brain diseases, preserving AIS integrity could have important therapeutic implications for ALS.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lefebvre-Omar</LastName><ForeName>Cynthia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, AP-HP, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Elise</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, AP-HP, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalle</LastName><ForeName>Carine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, AP-HP, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>d'Incamps</LastName><ForeName>Boris Lamotte</ForeName><Initials>BL</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris-Cit&#xe9;, CNRS, Saints-P&#xe8;res Paris Institute for the Neurosciences, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bigou</LastName><ForeName>St&#xe9;phanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, AP-HP, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daube</LastName><ForeName>Cl&#xe9;ment</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, AP-HP, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karpf</LastName><ForeName>L&#xe9;a</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, AP-HP, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davenne</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, AP-HP, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robil</LastName><ForeName>No&#xe9;mie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>GenoSplice Technology, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jost Mousseau</LastName><ForeName>Coline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, AP-HP, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blanchard</LastName><ForeName>St&#xe9;phane</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institut Pasteur, INSERM U1115, Unit&#xe9; Bioth&#xe9;rapies pour les Maladies Neurod&#xe9;g&#xe9;n&#xe9;ratives, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tournaire</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institut Pasteur, INSERM U1115, Unit&#xe9; Bioth&#xe9;rapies pour les Maladies Neurod&#xe9;g&#xe9;n&#xe9;ratives, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicaise</LastName><ForeName>Charles</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>URPhyM, NARILIS, Universit&#xe9; de Namur, Namur, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salachas</LastName><ForeName>Fran&#xe7;ois</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, AP-HP, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D&#xe9;partement de Neurologie, Assistance Publique H&#xf4;pitaux de Paris (APHP), Centre de R&#xe9;f&#xe9;rence SLA Ile de France, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lacomblez</LastName><ForeName>Lucette</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>D&#xe9;partement de Neurologie, Assistance Publique H&#xf4;pitaux de Paris (APHP), Centre de R&#xe9;f&#xe9;rence SLA Ile de France, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seilhean</LastName><ForeName>Danielle</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, AP-HP, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D&#xe9;partement de Neuropathologie, AP-HP, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lobsiger</LastName><ForeName>Christian S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, AP-HP, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Millecamps</LastName><ForeName>St&#xe9;phanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, AP-HP, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boill&#xe9;e</LastName><ForeName>S&#xe9;verine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, AP-HP, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bohl</LastName><ForeName>Delphine</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-8262-5642</Identifier><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, AP-HP, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France. delphine.bohl@icm-institute.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>16465</GrantID><Agency>AFM-T&#xe9;l&#xe9;thon</Agency><Country/></Grant><Grant><GrantID>EQU202103012581</GrantID><Agency>FRM</Agency><Country/></Grant><Grant><GrantID>ANR-10-LABX-73</GrantID><Agency>Labex Revive</Agency><Country/></Grant><Grant><GrantID>ALS-iPSC/AAP10</GrantID><Agency>Fondation Thierry Latran</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cell Mol Life Sci</MedlineTA><NlmUniqueID>9705402</NlmUniqueID><ISSNLinking>1420-682X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007382" MajorTopicYN="N">Intermediate Filaments</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Axonal initial segment</Keyword><Keyword MajorTopicYN="N">Degeneration</Keyword><Keyword MajorTopicYN="N">Human induced pluripotent stem cells</Keyword><Keyword MajorTopicYN="N">Motoneurons</Keyword><Keyword MajorTopicYN="N">Neurofilaments</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>15</Day><Hour>13</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>15</Day><Hour>11</Hour><Minute>5</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37184603</ArticleId><ArticleId IdType="pmc">PMC10185656</ArticleId><ArticleId IdType="doi">10.1007/s00018-023-04797-6</ArticleId><ArticleId IdType="pii">10.1007/s00018-023-04797-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mejzini R, Flynn LL, Pitout IL, Fletcher S, Wilton SD, Akkari PA. ALS genetics, mechanisms, and therapeutics: where are we now? Front Neurosci. 2019;13:1310. doi: 10.3389/fnins.2019.01310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller TM, Cudkowicz ME, Genge A, et al. Trial of antisense oligonucleotide tofersen for SOD1 ALS. N Engl J Med. 2022;387:1099&#x2013;1110. doi: 10.1056/NEJMoa2204705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2204705</ArticleId><ArticleId IdType="pubmed">36129998</ArticleId></ArticleIdList></Reference><Reference><Citation>Falzone YM, Russo T, Domi T, et al. Current application of neurofilaments in amyotrophic lateral sclerosis and future perspectives. Neural Regen Res. 2021;16:1985&#x2013;1991. doi: 10.4103/1673-5374.308072.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.308072</ArticleId><ArticleId IdType="pmc">PMC8343335</ArticleId><ArticleId IdType="pubmed">33642372</ArticleId></ArticleIdList></Reference><Reference><Citation>Vacchiano V, Mastrangelo A, Zenesini C, et al. Plasma and CSF neurofilament light chain in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study. Front Aging Neurosci. 2021;13:753242. doi: 10.3389/fnagi.2021.753242.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2021.753242</ArticleId><ArticleId IdType="pmc">PMC8569186</ArticleId><ArticleId IdType="pubmed">34744694</ArticleId></ArticleIdList></Reference><Reference><Citation>Zucchi E, Bonetto V, Soraru G, et al. Neurofilaments in motor neuron disorders: towards promising diagnostic and prognostic biomarkers. Mol Neurodegener. 2020;15:58. doi: 10.1186/s13024-020-00406-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00406-3</ArticleId><ArticleId IdType="pmc">PMC7559190</ArticleId><ArticleId IdType="pubmed">33059698</ArticleId></ArticleIdList></Reference><Reference><Citation>Witzel S, Frauhammer F, Steinacker P, et al. Neurofilament light and heterogeneity of disease progression in amyotrophic lateral sclerosis: development and validation of a prediction model to improve interventional trials. Transl Neurodegener. 2021;10:31. doi: 10.1186/s40035-021-00257-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-021-00257-y</ArticleId><ArticleId IdType="pmc">PMC8390195</ArticleId><ArticleId IdType="pubmed">34433481</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou YN, Chen YH, Dong SQ, et al. Role of blood neurofilaments in the prognosis of amyotrophic lateral sclerosis: a meta-analysis. Front Neurol. 2021;12:712245. doi: 10.3389/fneur.2021.712245.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.712245</ArticleId><ArticleId IdType="pmc">PMC8526968</ArticleId><ArticleId IdType="pubmed">34690913</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray E, Oeckl P, Amador MDM, et al. A multi-center study of neurofilament assay reliability and inter-laboratory variability. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:452&#x2013;458. doi: 10.1080/21678421.2020.1779300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1779300</ArticleId><ArticleId IdType="pubmed">32558597</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosengren LE, Karlsson JE, Karlsson JO, Persson LI, Wikkelso C. Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF. J Neurochem. 1996;67:2013&#x2013;2018. doi: 10.1046/j.1471-4159.1996.67052013.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.1996.67052013.x</ArticleId><ArticleId IdType="pubmed">8863508</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano A, Donnenfeld H, Sasaki S, Nakano I. Fine structural observations of neurofilamentous changes in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 1984;43:461&#x2013;470. doi: 10.1097/00005072-198409000-00001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-198409000-00001</ArticleId><ArticleId IdType="pubmed">6540799</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S, Maruyama S, Yamane K, Sakuma H, Takeishi M. Ultrastructure of swollen proximal axons of anterior horn neurons in motor neuron disease. J Neurol Sci. 1990;97:233&#x2013;240. doi: 10.1016/0022-510x(90)90221-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510x(90)90221-8</ArticleId><ArticleId IdType="pubmed">2401898</ArticleId></ArticleIdList></Reference><Reference><Citation>Rouleau GA, Clark AW, Rooke K, et al. SOD1 mutation is associated with accumulation of neurofilaments in amyotrophic lateral sclerosis. Ann Neurol. 1996;39:128&#x2013;131. doi: 10.1002/ana.410390119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410390119</ArticleId><ArticleId IdType="pubmed">8572658</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendonca DM, Chimelli L, Martinez AM. Quantitative evidence for neurofilament heavy subunit aggregation in motor neurons of spinal cords of patients with amyotrophic lateral sclerosis. Braz J Med Biol Res. 2005;38:925&#x2013;933. doi: 10.1590/s0100-879x2005000600015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/s0100-879x2005000600015</ArticleId><ArticleId IdType="pubmed">15933787</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato S. Amyotrophic lateral sclerosis models and human neuropathology: similarities and differences. Acta Neuropathol. 2008;115:97&#x2013;114. doi: 10.1007/s00401-007-0308-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-007-0308-4</ArticleId><ArticleId IdType="pubmed">18026741</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizusawa H, Matsumoto S, Yen SH, Hirano A, Rojas-Corona RR, Donnenfeld H. Focal accumulation of phosphorylated neurofilaments within anterior horn cell in familial amyotrophic lateral sclerosis. Acta Neuropathol. 1989;79:37&#x2013;43. doi: 10.1007/BF00308955.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00308955</ArticleId><ArticleId IdType="pubmed">2511732</ArticleId></ArticleIdList></Reference><Reference><Citation>Muratet F, Teyssou E, Chiot A, et al. Impact of a frequent nearsplice SOD1 variant in amyotrophic lateral sclerosis: optimising SOD1 genetic screening for gene therapy opportunities. J Neurol Neurosurg Psychiatry. 2021;92:942&#x2013;949. doi: 10.1136/jnnp-2020-325921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-325921</ArticleId><ArticleId IdType="pubmed">33785574</ArticleId></ArticleIdList></Reference><Reference><Citation>Collard JF, Cote F, Julien JP. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature. 1995;375:61&#x2013;64. doi: 10.1038/375061a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/375061a0</ArticleId><ArticleId IdType="pubmed">7536898</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z, Cork LC, Griffin JW, Cleveland DW. Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell. 1993;73:23&#x2013;33. doi: 10.1016/0092-8674(93)90157-l.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(93)90157-l</ArticleId><ArticleId IdType="pubmed">8462100</ArticleId></ArticleIdList></Reference><Reference><Citation>Julien JP. Neurofilaments and motor neuron disease. Trends Cell Biol. 1997;7:243&#x2013;249. doi: 10.1016/S0962-8924(97)01049-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0962-8924(97)01049-0</ArticleId><ArticleId IdType="pubmed">17708953</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S, Warita H, Abe K, Iwata M. Impairment of axonal transport in the axon hillock and the initial segment of anterior horn neurons in transgenic mice with a G93A mutant SOD1 gene. Acta Neuropathol. 2005;110:48&#x2013;56. doi: 10.1007/s00401-005-1021-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-005-1021-9</ArticleId><ArticleId IdType="pubmed">15920660</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S, Maruyama S. Increase in diameter of the axonal initial segment is an early change in amyotrophic lateral sclerosis. J Neurol Sci. 1992;110:114&#x2013;120. doi: 10.1016/0022-510x(92)90017-f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510x(92)90017-f</ArticleId><ArticleId IdType="pubmed">1506850</ArticleId></ArticleIdList></Reference><Reference><Citation>Leterrier C. The axon initial segment, 50years later: a nexus for neuronal organization and function. Curr Top Membr. 2016;77:185&#x2013;233. doi: 10.1016/bs.ctm.2015.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.ctm.2015.10.005</ArticleId><ArticleId IdType="pubmed">26781833</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamdan H, Lim BC, Torii T, et al. Mapping axon initial segment structure and function by multiplexed proximity biotinylation. Nat Commun. 2020;11:100. doi: 10.1038/s41467-019-13658-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-13658-5</ArticleId><ArticleId IdType="pmc">PMC6941957</ArticleId><ArticleId IdType="pubmed">31900387</ArticleId></ArticleIdList></Reference><Reference><Citation>Quistgaard EM, Nissen JD, Hansen S, Nissen P. Mind the gap: molecular architecture of the axon initial segment&#x2014;from fold prediction to a mechanistic model of function? J Mol Biol. 2021;433:167176. doi: 10.1016/j.jmb.2021.167176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2021.167176</ArticleId><ArticleId IdType="pubmed">34303720</ArticleId></ArticleIdList></Reference><Reference><Citation>Eichel K, Shen K. The function of the axon initial segment in neuronal polarity. Dev Biol. 2022;489:47&#x2013;54. doi: 10.1016/j.ydbio.2022.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ydbio.2022.05.016</ArticleId><ArticleId IdType="pubmed">35640681</ArticleId></ArticleIdList></Reference><Reference><Citation>Eichel K, Uenaka T, Belapurkar V, et al. Endocytosis in the axon initial segment maintains neuronal polarity. Nature. 2022;609:128&#x2013;135. doi: 10.1038/s41586-022-05074-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05074-5</ArticleId><ArticleId IdType="pmc">PMC9433327</ArticleId><ArticleId IdType="pubmed">35978188</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones SL, Svitkina TM. Axon initial segment cytoskeleton: architecture, development, and role in neuron polarity. Neural Plast. 2016;2016:6808293. doi: 10.1155/2016/6808293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/6808293</ArticleId><ArticleId IdType="pmc">PMC4967436</ArticleId><ArticleId IdType="pubmed">27493806</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae JS, Simon NG, Menon P, Vucic S, Kiernan MC. The puzzling case of hyperexcitability in amyotrophic lateral sclerosis. J Clin Neurol. 2013;9:65&#x2013;74. doi: 10.3988/jcn.2013.9.2.65.</Citation><ArticleIdList><ArticleId IdType="doi">10.3988/jcn.2013.9.2.65</ArticleId><ArticleId IdType="pmc">PMC3633193</ArticleId><ArticleId IdType="pubmed">23626643</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwai Y, Shibuya K, Misawa S, et al. Axonal dysfunction precedes motor neuronal death in amyotrophic lateral sclerosis. PLoS ONE. 2016;11:e0158596. doi: 10.1371/journal.pone.0158596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0158596</ArticleId><ArticleId IdType="pmc">PMC4934877</ArticleId><ArticleId IdType="pubmed">27383069</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemonnier T, Blanchard S, Toli D, et al. Modeling neuronal defects associated with a lysosomal disorder using patient-derived induced pluripotent stem cells. Hum Mol Genet. 2011;20:3653&#x2013;3666. doi: 10.1093/hmg/ddr285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr285</ArticleId><ArticleId IdType="pubmed">21685203</ArticleId></ArticleIdList></Reference><Reference><Citation>Toli D, Buttigieg D, Blanchard S, et al. Modeling amyotrophic lateral sclerosis in pure human iPSc-derived motor neurons isolated by a novel FACS double selection technique. Neurobiol Dis. 2015;82:269&#x2013;280. doi: 10.1016/j.nbd.2015.06.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2015.06.011</ArticleId><ArticleId IdType="pubmed">26107889</ArticleId></ArticleIdList></Reference><Reference><Citation>Millecamps S, Boillee S, Le Ber I, et al. Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes. J Med Genet. 2012;49:258&#x2013;263. doi: 10.1136/jmedgenet-2011-100699.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmedgenet-2011-100699</ArticleId><ArticleId IdType="pubmed">22499346</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruntraeger M, Byrne M, Long K, Bassett AR. Editing the genome of human induced pluripotent stem cells using CRISPR/Cas9 ribonucleoprotein complexes. Methods Mol Biol. 2019;1961:153&#x2013;183. doi: 10.1007/978-1-4939-9170-9_11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-9170-9_11</ArticleId><ArticleId IdType="pubmed">30912046</ArticleId></ArticleIdList></Reference><Reference><Citation>Maury Y, Come J, Piskorowski RA, et al. Combinatorial analysis of developmental cues efficiently converts human pluripotent stem cells into multiple neuronal subtypes. Nat Biotechnol. 2015;33:89&#x2013;96. doi: 10.1038/nbt.3049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3049</ArticleId><ArticleId IdType="pubmed">25383599</ArticleId></ArticleIdList></Reference><Reference><Citation>Senol AD, Pinto G, Beau M, et al. Alterations of the axon initial segment in multiple sclerosis grey matter. Brain Commun. 2022;4:fcac284. doi: 10.1093/braincomms/fcac284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcac284</ArticleId><ArticleId IdType="pmc">PMC9700164</ArticleId><ArticleId IdType="pubmed">36451656</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A, Davis CA, Schlesinger F, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15&#x2013;21. doi: 10.1093/bioinformatics/bts635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts635</ArticleId><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Noli L, Capalbo A, Ogilvie C, Khalaf Y, Ilic D. Discordant growth of monozygotic twins starts at the blastocyst stage: a case study. Stem Cell Rep. 2015;5:946&#x2013;953. doi: 10.1016/j.stemcr.2015.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2015.10.006</ArticleId><ArticleId IdType="pmc">PMC4682124</ArticleId><ArticleId IdType="pubmed">26584541</ArticleId></ArticleIdList></Reference><Reference><Citation>Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. doi: 10.1186/s13059-014-0550-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-014-0550-8</ArticleId><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Genin EC, Madji Hounoum B, Bannwarth S, et al. Mitochondrial defect in muscle precedes neuromuscular junction degeneration and motor neuron death in CHCHD10(S59L/+) mouse. Acta Neuropathol. 2019;138:123&#x2013;145. doi: 10.1007/s00401-019-01988-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-01988-z</ArticleId><ArticleId IdType="pubmed">30874923</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W, Naujock M, Fumagalli L, et al. HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients. Nat Commun. 2017;8:861. doi: 10.1038/s41467-017-00911-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00911-y</ArticleId><ArticleId IdType="pmc">PMC5636840</ArticleId><ArticleId IdType="pubmed">29021520</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijssen J, Comley LH, Hedlund E. Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis. Acta Neuropathol. 2017;133:863&#x2013;885. doi: 10.1007/s00401-017-1708-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1708-8</ArticleId><ArticleId IdType="pmc">PMC5427160</ArticleId><ArticleId IdType="pubmed">28409282</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragagnin AMG, Shadfar S, Vidal M, Jamali MS, Atkin JD. Motor neuron susceptibility in ALS/FTD. Front Neurosci. 2019;13:532. doi: 10.3389/fnins.2019.00532.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00532</ArticleId><ArticleId IdType="pmc">PMC6610326</ArticleId><ArticleId IdType="pubmed">31316328</ArticleId></ArticleIdList></Reference><Reference><Citation>Sagner A, Briscoe J. Establishing neuronal diversity in the spinal cord: a time and a place. Development. 2019 doi: 10.1242/dev.182154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.182154</ArticleId><ArticleId IdType="pubmed">31767567</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu DC, Niu T, Alaynick WA. Molecular and cellular development of spinal cord locomotor circuitry. Front Mol Neurosci. 2015;8:25. doi: 10.3389/fnmol.2015.00025.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2015.00025</ArticleId><ArticleId IdType="pmc">PMC4468382</ArticleId><ArticleId IdType="pubmed">26136656</ArticleId></ArticleIdList></Reference><Reference><Citation>Novitch BG, Chen AI, Jessell TM. Coordinate regulation of motor neuron subtype identity and pan-neuronal properties by the bHLH repressor Olig2. Neuron. 2001;31:773&#x2013;789. doi: 10.1016/s0896-6273(01)00407-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0896-6273(01)00407-x</ArticleId><ArticleId IdType="pubmed">11567616</ArticleId></ArticleIdList></Reference><Reference><Citation>De Marco Garcia NV, Jessell TM. Early motor neuron pool identity and muscle nerve trajectory defined by postmitotic restrictions in Nkx6.1 activity. Neuron. 2008;57:217&#x2013;231. doi: 10.1016/j.neuron.2007.11.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2007.11.033</ArticleId><ArticleId IdType="pmc">PMC2276619</ArticleId><ArticleId IdType="pubmed">18215620</ArticleId></ArticleIdList></Reference><Reference><Citation>Amoroso MW, Croft GF, Williams DJ, et al. Accelerated high-yield generation of limb-innervating motor neurons from human stem cells. J Neurosci. 2013;33:574&#x2013;586. doi: 10.1523/JNEUROSCI.0906-12.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0906-12.2013</ArticleId><ArticleId IdType="pmc">PMC3711539</ArticleId><ArticleId IdType="pubmed">23303937</ArticleId></ArticleIdList></Reference><Reference><Citation>Arber S, Han B, Mendelsohn M, Smith M, Jessell TM, Sockanathan S. Requirement for the homeobox gene Hb9 in the consolidation of motor neuron identity. Neuron. 1999;23:659&#x2013;674. doi: 10.1016/S0896-6273(01)80026-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(01)80026-X</ArticleId><ArticleId IdType="pubmed">10482234</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaler J, Harrison K, Sharma K, Lettieri K, Kehrl J, Pfaff SL. Active suppression of interneuron programs within developing motor neurons revealed by analysis of homeodomain factor HB9. Neuron. 1999;23:675&#x2013;687. doi: 10.1016/s0896-6273(01)80027-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0896-6273(01)80027-1</ArticleId><ArticleId IdType="pubmed">10482235</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamotte d'Incamps B, Bhumbra GS, Foster JD, Beato M, Ascher P. Segregation of glutamatergic and cholinergic transmission at the mixed motoneuron Renshaw cell synapse. Sci Rep. 2017;7:4037. doi: 10.1038/s41598-017-04266-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-04266-8</ArticleId><ArticleId IdType="pmc">PMC5481398</ArticleId><ArticleId IdType="pubmed">28642492</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum JA, Klemm S, Shadrach JL, et al. Single-cell transcriptomic analysis of the adult mouse spinal cord reveals molecular diversity of autonomic and skeletal motor neurons. Nat Neurosci. 2021;24:572&#x2013;583. doi: 10.1038/s41593-020-00795-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00795-0</ArticleId><ArticleId IdType="pmc">PMC8016743</ArticleId><ArticleId IdType="pubmed">33589834</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang CJ, Chang MY, Lee YC, et al. Nck2 is essential for limb trajectory selection by spinal motor axons. Dev Dyn. 2018;247:1043&#x2013;1056. doi: 10.1002/dvdy.24656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dvdy.24656</ArticleId><ArticleId IdType="pubmed">30016580</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai WL, Chang CJ, Wang CY, et al. Paxillin is required for proper spinal motor axon growth into the limb. J Neurosci. 2021;41:3808&#x2013;3821. doi: 10.1523/JNEUROSCI.2863-20.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2863-20.2021</ArticleId><ArticleId IdType="pmc">PMC8084319</ArticleId><ArticleId IdType="pubmed">33727334</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkaslasi MR, Piccus ZE, Hareendran S, et al. Single nucleus RNA-sequencing defines unexpected diversity of cholinergic neuron types in the adult mouse spinal cord. Nat Commun. 2021;12:2471. doi: 10.1038/s41467-021-22691-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-22691-2</ArticleId><ArticleId IdType="pmc">PMC8087807</ArticleId><ArticleId IdType="pubmed">33931636</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweingruber C, Hedlund E. The cell autonomous and non-cell autonomous aspects of neuronal vulnerability and resilience in amyotrophic lateral sclerosis. Biology (Basel) 2022 doi: 10.3390/biology11081191.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology11081191</ArticleId><ArticleId IdType="pmc">PMC9405388</ArticleId><ArticleId IdType="pubmed">36009818</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S, Maruyama S, Yamane K, Sakuma H, Takeishi M. Swellings of proximal axons in a case of motor neuron disease. Ann Neurol. 1989;25:520&#x2013;522. doi: 10.1002/ana.410250520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410250520</ArticleId><ArticleId IdType="pubmed">2774495</ArticleId></ArticleIdList></Reference><Reference><Citation>He L, Jiang W, Li J, Wang C. Crystal structure of Ankyrin-G in complex with a fragment of Neurofascin reveals binding mechanisms required for integrity of the axon initial segment. J Biol Chem. 2022;298:102272. doi: 10.1016/j.jbc.2022.102272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2022.102272</ArticleId><ArticleId IdType="pmc">PMC9396398</ArticleId><ArticleId IdType="pubmed">35850303</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang CY, Rasband MN. Axon initial segments: structure, function, and disease. Ann N Y Acad Sci. 2018;1420:46&#x2013;61. doi: 10.1111/nyas.13718.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nyas.13718</ArticleId><ArticleId IdType="pmc">PMC5992072</ArticleId><ArticleId IdType="pubmed">29749636</ArticleId></ArticleIdList></Reference><Reference><Citation>Buhusi M, Midkiff BR, Gates AM, Richter M, Schachner M, Maness PF. Close homolog of L1 is an enhancer of integrin-mediated cell migration. J Biol Chem. 2003;278:25024&#x2013;25031. doi: 10.1074/jbc.M303084200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M303084200</ArticleId><ArticleId IdType="pubmed">12721290</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandawijaya J, Bamford RA, Burbach JPH, Oguro-Ando A. Cell adhesion molecules involved in neurodevelopmental pathways implicated in 3p-deletion syndrome and autism spectrum disorder. Front Cell Neurosci. 2020;14:611379. doi: 10.3389/fncel.2020.611379.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.611379</ArticleId><ArticleId IdType="pmc">PMC7838543</ArticleId><ArticleId IdType="pubmed">33519384</ArticleId></ArticleIdList></Reference><Reference><Citation>Loers G, Theis T, Baixia Hao H, et al. Interplay in neural functions of cell adhesion molecule close homolog of L1 (CHL1) and Programmed Cell Death 6 (PDCD6) FASEB Bioadv. 2022;4:43&#x2013;59. doi: 10.1096/fba.2021-00027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fba.2021-00027</ArticleId><ArticleId IdType="pmc">PMC8728108</ArticleId><ArticleId IdType="pubmed">35024572</ArticleId></ArticleIdList></Reference><Reference><Citation>Srinivasan Y, Elmer L, Davis J, Bennett V, Angelides K. Ankyrin and spectrin associate with voltage-dependent sodium channels in brain. Nature. 1988;333:177&#x2013;180. doi: 10.1038/333177a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/333177a0</ArticleId><ArticleId IdType="pubmed">2452986</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkins SM, Bennett V. Ankyrin-G coordinates assembly of the spectrin-based membrane skeleton, voltage-gated sodium channels, and L1 CAMs at Purkinje neuron initial segments. J Cell Biol. 2001;155:739&#x2013;746. doi: 10.1083/jcb.200109026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200109026</ArticleId><ArticleId IdType="pmc">PMC2150881</ArticleId><ArticleId IdType="pubmed">11724816</ArticleId></ArticleIdList></Reference><Reference><Citation>Devlin AC, Burr K, Borooah S, et al. Human iPSC-derived motoneurons harbouring TARDBP or C9ORF72 ALS mutations are dysfunctional despite maintaining viability. Nat Commun. 2015;6:5999. doi: 10.1038/ncomms6999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms6999</ArticleId><ArticleId IdType="pmc">PMC4338554</ArticleId><ArticleId IdType="pubmed">25580746</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasen JS, De Camilli A, Wang B, Tucker PW, Jessell TM. Hox repertoires for motor neuron diversity and connectivity gated by a single accessory factor, FoxP1. Cell. 2008;134:304&#x2013;316. doi: 10.1016/j.cell.2008.06.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2008.06.019</ArticleId><ArticleId IdType="pubmed">18662545</ArticleId></ArticleIdList></Reference><Reference><Citation>Maugeri G, D'Amico AG, Morello G, Reglodi D, Cavallaro S, D'Agata V. Differential vulnerability of oculomotor versus hypoglossal nucleus during ALS: involvement of PACAP. Front Neurosci. 2020;14:805. doi: 10.3389/fnins.2020.00805.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00805</ArticleId><ArticleId IdType="pmc">PMC7432287</ArticleId><ArticleId IdType="pubmed">32848572</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawrot J, Imhof S, Wainger BJ. Modeling cell-autonomous motor neuron phenotypes in ALS using iPSCs. Neurobiol Dis. 2020;134:104680. doi: 10.1016/j.nbd.2019.104680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104680</ArticleId><ArticleId IdType="pmc">PMC7002167</ArticleId><ArticleId IdType="pubmed">31759135</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao A, Pan Y, Cai S. Patient-specific cells for modeling and decoding amyotrophic lateral sclerosis: advances and challenges. Stem Cell Rev Rep. 2020;16:482&#x2013;502. doi: 10.1007/s12015-019-09946-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-019-09946-8</ArticleId><ArticleId IdType="pubmed">31916190</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Rhodes NR, Abdolvahabi A, et al. Deamidation of asparagine to aspartate destabilizes Cu, Zn superoxide dismutase, accelerates fibrillization, and mirrors ALS-linked mutations. J Am Chem Soc. 2013;135:15897&#x2013;15908. doi: 10.1021/ja407801x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ja407801x</ArticleId><ArticleId IdType="pubmed">24066782</ArticleId></ArticleIdList></Reference><Reference><Citation>Volkening K, Leystra-Lantz C, Yang W, Jaffee H, Strong MJ. Tar DNA binding protein of 43 kDa (TDP-43), 14&#x2013;3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS) Brain Res. 2009;1305:168&#x2013;182. doi: 10.1016/j.brainres.2009.09.105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2009.09.105</ArticleId><ArticleId IdType="pubmed">19815002</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook CN, Wu Y, Odeh HM, et al. C9orf72 poly(GR) aggregation induces TDP-43 proteinopathy. Sci Transl Med. 2020 doi: 10.1126/scitranslmed.abb3774.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abb3774</ArticleId><ArticleId IdType="pmc">PMC7989020</ArticleId><ArticleId IdType="pubmed">32878979</ArticleId></ArticleIdList></Reference><Reference><Citation>Suthar SK, Lee SY. The role of superoxide dismutase 1 in amyotrophic lateral sclerosis: identification of signaling pathways, regulators, molecular interaction networks, and biological functions through bioinformatics. Brain Sci. 2023 doi: 10.3390/brainsci13010151.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci13010151</ArticleId><ArticleId IdType="pmc">PMC9857031</ArticleId><ArticleId IdType="pubmed">36672132</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo Y, Lee J, Lee SY, Kwon I, Cho H. Poly-dipeptides produced from C9orf72 hexanucleotide repeats cause selective motor neuron hyperexcitability in ALS. Proc Natl Acad Sci U S A. 2022;119:e2113813119. doi: 10.1073/pnas.2113813119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2113813119</ArticleId><ArticleId IdType="pmc">PMC8931230</ArticleId><ArticleId IdType="pubmed">35259014</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, Qian K, Du Z, et al. Modeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons. Cell Stem Cell. 2014 doi: 10.1016/j.stem.2014.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2014.02.004</ArticleId><ArticleId IdType="pmc">PMC4230530</ArticleId><ArticleId IdType="pubmed">24704493</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreiter N, Pal A, Lojewski X, et al. Age-dependent neurodegeneration and organelle transport deficiencies in mutant TDP43 patient-derived neurons are independent of TDP43 aggregation. Neurobiol Dis. 2018;115:167&#x2013;181. doi: 10.1016/j.nbd.2018.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.03.010</ArticleId><ArticleId IdType="pubmed">29630989</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X, Song J, Huang H, Chen H, Qian K. Modeling hallmark pathology using motor neurons derived from the family and sporadic amyotrophic lateral sclerosis patient-specific iPS cells. Stem Cell Res Ther. 2018;9:315. doi: 10.1186/s13287-018-1048-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-018-1048-1</ArticleId><ArticleId IdType="pmc">PMC6238404</ArticleId><ArticleId IdType="pubmed">30442180</ArticleId></ArticleIdList></Reference><Reference><Citation>Millecamps S, Julien JP. Axonal transport deficits and neurodegenerative diseases. Nat Rev Neurosci. 2013;14:161&#x2013;176. doi: 10.1038/nrn3380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3380</ArticleId><ArticleId IdType="pubmed">23361386</ArticleId></ArticleIdList></Reference><Reference><Citation>Didonna A, Opal P. The role of neurofilament aggregation in neurodegeneration: lessons from rare inherited neurological disorders. Mol Neurodegener. 2019;14:19. doi: 10.1186/s13024-019-0318-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-019-0318-4</ArticleId><ArticleId IdType="pmc">PMC6524292</ArticleId><ArticleId IdType="pubmed">31097008</ArticleId></ArticleIdList></Reference><Reference><Citation>Sainio MT, Rasila T, Molchanova SM, et al. Neurofilament light regulates axon caliber, synaptic activity, and organelle trafficking in cultured human motor neurons. Front Cell Dev Biol. 2021;9:820105. doi: 10.3389/fcell.2021.820105.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2021.820105</ArticleId><ArticleId IdType="pmc">PMC8883324</ArticleId><ArticleId IdType="pubmed">35237613</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao MV, Mohan PS, Kumar A, et al. The myosin Va head domain binds to the neurofilament-L rod and modulates endoplasmic reticulum (ER) content and distribution within axons. PLoS ONE. 2011;6:e17087. doi: 10.1371/journal.pone.0017087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0017087</ArticleId><ArticleId IdType="pmc">PMC3040190</ArticleId><ArticleId IdType="pubmed">21359212</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano A, Nakano I, Kurland LT, Mulder DW, Holley PW, Saccomanno G. Fine structural study of neurofibrillary changes in a family with amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 1984;43:471&#x2013;480. doi: 10.1097/00005072-198409000-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-198409000-00002</ArticleId><ArticleId IdType="pubmed">6540800</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S, Iwata M. Impairment of fast axonal transport in the proximal axons of anterior horn neurons in amyotrophic lateral sclerosis. Neurology. 1996;47:535&#x2013;540. doi: 10.1212/wnl.47.2.535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.47.2.535</ArticleId><ArticleId IdType="pubmed">8757033</ArticleId></ArticleIdList></Reference><Reference><Citation>Magrane J, Cortez C, Gan WB, Manfredi G. Abnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models. Hum Mol Genet. 2014;23:1413&#x2013;1424. doi: 10.1093/hmg/ddt528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt528</ArticleId><ArticleId IdType="pmc">PMC3929084</ArticleId><ArticleId IdType="pubmed">24154542</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson TL, Cleveland DW. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat Neurosci. 1999;2:50&#x2013;56. doi: 10.1038/4553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/4553</ArticleId><ArticleId IdType="pubmed">10195180</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbs KL, Kalmar B, Rhymes ER, et al. Inhibiting p38 MAPK alpha rescues axonal retrograde transport defects in a mouse model of ALS. Cell Death Dis. 2018;9:596. doi: 10.1038/s41419-018-0624-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-0624-8</ArticleId><ArticleId IdType="pmc">PMC5964181</ArticleId><ArticleId IdType="pubmed">29789529</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli L, Young FL, Boeynaems S, et al. C9orf72-derived arginine-containing dipeptide repeats associate with axonal transport machinery and impede microtubule-based motility. Sci Adv. 2021 doi: 10.1126/sciadv.abg3013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abg3013</ArticleId><ArticleId IdType="pmc">PMC8034861</ArticleId><ArticleId IdType="pubmed">33837088</ArticleId></ArticleIdList></Reference><Reference><Citation>Abo-Rady M, Kalmbach N, Pal A, et al. Knocking out C9ORF72 exacerbates axonal trafficking defects associated with hexanucleotide repeat expansion and reduces levels of heat shock proteins. Stem Cell Rep. 2020;14:390&#x2013;405. doi: 10.1016/j.stemcr.2020.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2020.01.010</ArticleId><ArticleId IdType="pmc">PMC7066330</ArticleId><ArticleId IdType="pubmed">32084385</ArticleId></ArticleIdList></Reference><Reference><Citation>Fazal R, Boeynaems S, Swijsen A, et al. HDAC6 inhibition restores TDP-43 pathology and axonal transport defects in human motor neurons with TARDBP mutations. EMBO J. 2021;40:e106177. doi: 10.15252/embj.2020106177.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020106177</ArticleId><ArticleId IdType="pmc">PMC8013789</ArticleId><ArticleId IdType="pubmed">33694180</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W, Stoklund Dittlau K, Van Den Bosch L. Axonal transport defects and neurodegeneration: molecular mechanisms and therapeutic implications. Semin Cell Dev Biol. 2020;99:133&#x2013;150. doi: 10.1016/j.semcdb.2019.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2019.07.010</ArticleId><ArticleId IdType="pubmed">31542222</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki N, Akiyama T, Warita H, Aoki M. Omics approach to axonal dysfunction of motor neurons in amyotrophic lateral sclerosis (ALS) Front Neurosci. 2020;14:194. doi: 10.3389/fnins.2020.00194.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00194</ArticleId><ArticleId IdType="pmc">PMC7109447</ArticleId><ArticleId IdType="pubmed">32269505</ArticleId></ArticleIdList></Reference><Reference><Citation>Theunissen F, West PK, Brennan S, et al. New perspectives on cytoskeletal dysregulation and mitochondrial mislocalization in amyotrophic lateral sclerosis. Transl Neurodegener. 2021;10:46. doi: 10.1186/s40035-021-00272-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-021-00272-z</ArticleId><ArticleId IdType="pmc">PMC8597313</ArticleId><ArticleId IdType="pubmed">34789332</ArticleId></ArticleIdList></Reference><Reference><Citation>Malka-Gibor E, Kornreich M, Laser-Azogui A, et al. Phosphorylation-induced mechanical regulation of intrinsically disordered neurofilament proteins. Biophys J. 2017;112:892&#x2013;900. doi: 10.1016/j.bpj.2016.12.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2016.12.050</ArticleId><ArticleId IdType="pmc">PMC5355543</ArticleId><ArticleId IdType="pubmed">28297648</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz-Lasso DC, Roma-Mateo C, Pallardo FV, Gonzalez-Cabo P. Much more than a scaffold: cytoskeletal proteins in neurological disorders. Cells. 2020 doi: 10.3390/cells9020358.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9020358</ArticleId><ArticleId IdType="pmc">PMC7072452</ArticleId><ArticleId IdType="pubmed">32033020</ArticleId></ArticleIdList></Reference><Reference><Citation>Errante LD, Wiche G, Shaw G. Distribution of plectin, an intermediate filament-associated protein, in the adult rat central nervous system. J Neurosci Res. 1994;37:515&#x2013;528. doi: 10.1002/jnr.490370411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.490370411</ArticleId><ArticleId IdType="pubmed">8021973</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanon MJ, Walko G, Winter L, Wiche G. Plectin-intermediate filament partnership in skin, skeletal muscle, and peripheral nerve. Histochem Cell Biol. 2013;140:33&#x2013;53. doi: 10.1007/s00418-013-1102-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00418-013-1102-0</ArticleId><ArticleId IdType="pmc">PMC3695321</ArticleId><ArticleId IdType="pubmed">23748243</ArticleId></ArticleIdList></Reference><Reference><Citation>Song AH, Wang D, Chen G, et al. A selective filter for cytoplasmic transport at the axon initial segment. Cell. 2009;136:1148&#x2013;1160. doi: 10.1016/j.cell.2009.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2009.01.016</ArticleId><ArticleId IdType="pubmed">19268344</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimori K, Ishikawa M, Otomo A, et al. Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent. Nat Med. 2018;24:1579&#x2013;1589. doi: 10.1038/s41591-018-0140-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0140-5</ArticleId><ArticleId IdType="pubmed">30127392</ArticleId></ArticleIdList></Reference><Reference><Citation>Kole MH, Ilschner SU, Kampa BM, Williams SR, Ruben PC, Stuart GJ. Action potential generation requires a high sodium channel density in the axon initial segment. Nat Neurosci. 2008;11:178&#x2013;186. doi: 10.1038/nn2040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn2040</ArticleId><ArticleId IdType="pubmed">18204443</ArticleId></ArticleIdList></Reference><Reference><Citation>Goethals S, Brette R. Theoretical relation between axon initial segment geometry and excitability. Elife. 2020 doi: 10.7554/eLife.53432.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.53432</ArticleId><ArticleId IdType="pmc">PMC7170651</ArticleId><ArticleId IdType="pubmed">32223890</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorincz A, Nusser Z. Cell-type-dependent molecular composition of the axon initial segment. J Neurosci. 2008;28:14329&#x2013;14340. doi: 10.1523/JNEUROSCI.4833-08.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4833-08.2008</ArticleId><ArticleId IdType="pmc">PMC2628579</ArticleId><ArticleId IdType="pubmed">19118165</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotterman TM, Carrasco DI, Housley SN, Nardelli P, Powers RK, Cope TC. Axon initial segment geometry in relation to motoneuron excitability. PLoS ONE. 2021;16:e0259918. doi: 10.1371/journal.pone.0259918.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0259918</ArticleId><ArticleId IdType="pmc">PMC8604372</ArticleId><ArticleId IdType="pubmed">34797870</ArticleId></ArticleIdList></Reference><Reference><Citation>Fekete A, Ankri N, Brette R, Debanne D. Neural excitability increases with axonal resistance between soma and axon initial segment. Proc Natl Acad Sci U S A. 2021 doi: 10.1073/pnas.2102217118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2102217118</ArticleId><ArticleId IdType="pmc">PMC8379991</ArticleId><ArticleId IdType="pubmed">34389672</ArticleId></ArticleIdList></Reference><Reference><Citation>Elbasiouny SM. Motoneuron excitability dysfunction in ALS: pseudo-mystery or authentic conundrum? J Physiol. 2022;600:4815&#x2013;4825. doi: 10.1113/JP283630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/JP283630</ArticleId><ArticleId IdType="pmc">PMC9669170</ArticleId><ArticleId IdType="pubmed">36178320</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonnevie VS, Dimintiyanova KP, Hedegaard A, et al. Shorter axon initial segments do not cause repetitive firing impairments in the adult presymptomatic G127X SOD-1 Amyotrophic Lateral Sclerosis mouse. Sci Rep. 2020;10:1280. doi: 10.1038/s41598-019-57314-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-57314-w</ArticleId><ArticleId IdType="pmc">PMC6987224</ArticleId><ArticleId IdType="pubmed">31992746</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorgensen HS, Jensen DB, Dimintiyanova KP, et al. Increased axon initial segment length results in increased Na(+) currents in spinal motoneurones at symptom onset in the G127X SOD1 mouse model of amyotrophic lateral sclerosis. Neuroscience. 2021;468:247&#x2013;264. doi: 10.1016/j.neuroscience.2020.11.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2020.11.016</ArticleId><ArticleId IdType="pubmed">33246068</ArticleId></ArticleIdList></Reference><Reference><Citation>Bos R, Rihan K, Quintana P, et al. Altered action potential waveform and shorter axonal initial segment in hiPSC-derived motor neurons with mutations in VRK1. Neurobiol Dis. 2022;164:105609. doi: 10.1016/j.nbd.2021.105609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2021.105609</ArticleId><ArticleId IdType="pubmed">34990802</ArticleId></ArticleIdList></Reference><Reference><Citation>Dangond F, Hwang D, Camelo S, et al. Molecular signature of late-stage human ALS revealed by expression profiling of postmortem spinal cord gray matter. Physiol Genom. 2004;16:229&#x2013;239. doi: 10.1152/physiolgenomics.00087.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physiolgenomics.00087.2001</ArticleId><ArticleId IdType="pubmed">14645737</ArticleId></ArticleIdList></Reference><Reference><Citation>Riva N, Clarelli F, Domi T, et al. Unraveling gene expression profiles in peripheral motor nerve from amyotrophic lateral sclerosis patients: insights into pathogenesis. Sci Rep. 2016;6:39297. doi: 10.1038/srep39297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep39297</ArticleId><ArticleId IdType="pmc">PMC5159906</ArticleId><ArticleId IdType="pubmed">27982123</ArticleId></ArticleIdList></Reference><Reference><Citation>Buffington SA, Rasband MN. The axon initial segment in nervous system disease and injury. Eur J Neurosci. 2011;34:1609&#x2013;1619. doi: 10.1111/j.1460-9568.2011.07875.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2011.07875.x</ArticleId><ArticleId IdType="pmc">PMC3482160</ArticleId><ArticleId IdType="pubmed">22103418</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon S, Piguel NH, Penzes P. Roles and mechanisms of ankyrin-G in neuropsychiatric disorders. Exp Mol Med. 2022;54:867&#x2013;877. doi: 10.1038/s12276-022-00798-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-022-00798-w</ArticleId><ArticleId IdType="pmc">PMC9356056</ArticleId><ArticleId IdType="pubmed">35794211</ArticleId></ArticleIdList></Reference><Reference><Citation>Teliska LH, Dalla Costa I, Sert O, Twiss JL, Rasband MN. Axon initial segments are required for efficient motor neuron axon regeneration and functional recovery of synapses. J Neurosci. 2022 doi: 10.1523/JNEUROSCI.1261-22.2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1261-22.2022</ArticleId><ArticleId IdType="pmc">PMC9636994</ArticleId><ArticleId IdType="pubmed">36096668</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin MA, Ziburkus J, Jankowsky J, Rasband MN. Amyloid-beta plaques disrupt axon initial segments. Exp Neurol. 2016;281:93&#x2013;98. doi: 10.1016/j.expneurol.2016.04.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2016.04.018</ArticleId><ArticleId IdType="pmc">PMC4877279</ArticleId><ArticleId IdType="pubmed">27109181</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohn PD, Huang CT, Yan R, et al. Pathogenic tau impairs axon initial segment plasticity and excitability homeostasis. Neuron. 2019;104:458&#x2013;470 e455. doi: 10.1016/j.neuron.2019.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.08.008</ArticleId><ArticleId IdType="pmc">PMC6880876</ArticleId><ArticleId IdType="pubmed">31542321</ArticleId></ArticleIdList></Reference><Reference><Citation>Schafer DP, Jha S, Liu F, Akella T, McCullough LD, Rasband MN. Disruption of the axon initial segment cytoskeleton is a new mechanism for neuronal injury. J Neurosci. 2009;29:13242&#x2013;13254. doi: 10.1523/JNEUROSCI.3376-09.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3376-09.2009</ArticleId><ArticleId IdType="pmc">PMC2801423</ArticleId><ArticleId IdType="pubmed">19846712</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Ciorraga M, Mendez P, et al. Formin activity and mDia1 contribute to maintain axon initial segment composition and structure. Mol Neurobiol. 2021;58:6153&#x2013;6169. doi: 10.1007/s12035-021-02531-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02531-6</ArticleId><ArticleId IdType="pmc">PMC8639558</ArticleId><ArticleId IdType="pubmed">34458961</ArticleId></ArticleIdList></Reference><Reference><Citation>Meichsner M, Doll T, Reddy D, Weisshaar B, Matus A. The low molecular weight form of microtubule-associated protein 2 is transported into both axons and dendrites. Neuroscience. 1993;54:873&#x2013;880. doi: 10.1016/0306-4522(93)90581-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0306-4522(93)90581-y</ArticleId><ArticleId IdType="pubmed">8341422</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoka V, Turk V, Turk B. Lysosomal cathepsins and their regulation in aging and neurodegeneration. Ageing Res Rev. 2016;32:22&#x2013;37. doi: 10.1016/j.arr.2016.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2016.04.010</ArticleId><ArticleId IdType="pubmed">27125852</ArticleId></ArticleIdList></Reference><Reference><Citation>Petzoldt AG, Gotz TWB, Driller JH, et al. RIM-binding protein couples synaptic vesicle recruitment to release sites. J Cell Biol. 2020 doi: 10.1083/jcb.201902059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201902059</ArticleId><ArticleId IdType="pmc">PMC7337501</ArticleId><ArticleId IdType="pubmed">32369542</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitale PM, Howse W, Gorbatyuk M. Neuronatin protein in health and disease. J Cell Physiol. 2017;232:477&#x2013;481. doi: 10.1002/jcp.25498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.25498</ArticleId><ArticleId IdType="pubmed">27442611</ArticleId></ArticleIdList></Reference><Reference><Citation>Hageman J, van Waarde MA, Zylicz A, Walerych D, Kampinga HH. The diverse members of the mammalian HSP70 machine show distinct chaperone-like activities. Biochem J. 2011;435:127&#x2013;142. doi: 10.1042/BJ20101247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20101247</ArticleId><ArticleId IdType="pubmed">21231916</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>